Table 2.

Cutaneous manifestations in pSS patients.

Clinical Manifestations	Number of Patients (%)
Xerostomia (n, %)	113 (91.12%)
Xerophthalmia (n, %)	75 (60.48%)
CM (n, %)	50 (40.32%)
Cutaneous vasculitis lesions (n, %)	34 (27.41%)
Non–palpable purpura	23 (18.54%)
Palpable purpura	10 (8.06%)
Cryoglobulinemic vasculitis (n, %)	8 (6.45%)
Leukocytoclastic vasculitis (n, %)	2 (1.61%)
Urticarial vasculitis (n, %)	1 (0.8%)
Non vasculitis lesions	66 (48.38%)
Xeroderma (n, %)	44 (35.48%)
Raynaud syndrome (n, %)	22 (17.74%)